Table 3.

Tumor Characteristics and Cancer Treatment by BMI status

Tumor Characteristics and Cancer Treatment	Cases		Controls
	Healthy (18.5–24.9)	Overweight/Obese (≥25)	Healthy (18.5–24.9)	Overweight/Obese (≥25)	P-Value (Chi-Square)
	N (%)	N (%)	N (%)	N (%)
Total	64	259	109	319
Gleason Score
<7	6 (32%)	13 (68%)	34 (28%)	89 (72%)	0.72
7	25 (16%)	132 (84%)	43 (23%)	146 (77%)	0.11
8+	28 (22%)	98 (78%)	16 (39%)	25 (61%)	0.03
Missing	5 (24%)	16 (76%)	16 (21%)	60 (79%)	0.79
Tumor grade
1	0 (0%)	4 (100%)	1 (14%)	6 (86%)	0.43
2	8 (22%)	29 (78%)	41 (27%)	112 (73%)	0.52
3	56 (20%)	226 (80%)	67 (25%)	198 (75%)	0.13
Missing	0 (0%)	0 (0%)	0 (0%)	3 (100%)
Positive Margins
Yes	18 (12%)	128 (88%)	42 (27%)	112 (73%)	0.001
No	39 (26%)	110 (74%)	50 (25%)	148 (75%)	0.85
Missing	7 (25%)	21 (75%)	17 (22%)	60 (78%)	0.75
Lymph nodes
Yes	6 (14%)	38 (86%)	11 (38%)	18 (62%)	0.02
No	44 (21%)	167 (79%)	68 (25%)	204 (75%)	0.28
Missing	14 (21%)	54 (79%)	30 (24%)	97 (76%)	0.63
PSA at diagnosis
0–6	12 (20%)	47 (80%)	14 (16%)	72 (84%)	0.53
7–10	5 (10%)	45 (90%)	35 (35%)	66 (65%)	0.001
11–18	11 (19=%)	46 (81%)	25 (27%)	68 (73%)	0.29
19+	20 (26%)	57 (74%)	17 (24%)	53 (76%)	0.81
Missing	16 (20%)	64 (80%)	18 (23%)	60 (77%)	0.64
Stage at diagnosis
2	14 (14%)	84 (86%)	54 (25%)	163 (75%)	0.03
3	40 (24%)	128 (76%)	42 (24%)	132 (76%)	0.94
4	10 (18%)	47 (82%)	13 (35%)	24 (65%)	0.05
Primary Treatment
Curative treatment > 6 months after diagnosis
Yes	47 (21%)	175 (79%)	69 (24%)	216 (76%)	0.42
No	17 (17%)	84 (83%)	40 (28%)	103 (72%)	0.04
Radiation-curative intent
Yes	15 (15%)	84 (85%)	10 (15%)	55 (85%)	0.97
No	49 (22%)	175 (78%)	99 (27%)	264 (73%)	0.14
ADT
Yes	3 (17%)	15 (83%)	5 (26%)	14 (74%)	0.48
No	61 (20%)	244 (80%)	104 (25%)	305 (75%)	0.09
Radiation without ADT	13 (14%)	82 (86%)	8 (13%)	53 (87%)	0.92
Radiation with ADT	2 (50%)	2 (50%)	2 (50%)	2 (50%)	1.00